American Regent, Inc. FDA Inspection Record
American Regent, Inc. is an FDA-registered facility (FEI 3010209784) located in New Albany, OH, US. Registered operations: LABEL; MANUFACTURE; PACK. RegDataLab tracks 5 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Jan 29, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 5 (4 VAI, 1 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 4, latest Apr 16, 2026
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jan 29, 2026 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Procedures for sterile drug products (21 CFR 211.113(b)) Rejecting When Specifications Not Met (21 CFR 211.84(e)) Investigations of discrepancies, failures (21 CFR 211.192) |
| Sep 30, 2022 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) |
| Oct 28, 2016 | No Action Indicated (NAI) | No citations listed |
| May 5, 2016 | Voluntary Action Indicated (VAI) | No citations listed |
| Mar 19, 2015 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Apr 16, 2026 | Class III | D-0494-2026 | Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous… Labeling: Missing Label |
| Apr 18, 2025 | Class II | D-0398-2025 | niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial… and 1 more product Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. |
| May 14, 2024 | Class II | D-0503-2024 | niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose… Lack of Assurance of Sterility. |
| May 13, 2024 | Class II | D-0507-2024 | Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose… Subpotent product in addition to having out-of-specification results for impurities. |
FDA record score
18 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
7 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jan 29, 2026 | 6 x 1 | 6 |
| Class II recall D-0398-2025, this FEI as the recalling firm | Apr 18, 2025 | 4 x 1 | 4 |
| Inspection classified VAI | Sep 30, 2022 | 6 x 0.6 | 3.6 |
| Class II recall D-0503-2024, this FEI as the recalling firm | May 14, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0507-2024, this FEI as the recalling firm | May 13, 2024 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | May 5, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 19, 2015 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing American Regent, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check American Regent, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- American Regent, Inc.
- Location
- New Albany, OH (US)
- Registration Expires
- Dec 31, 2027
- Operations
- LABEL; MANUFACTURE; PACK
- Source
- decrs